Safety and Immunogenicity of Pvs25-IMX313/Matrix-M1 Vaccine
Clinical trial NCT05270265 · TERMINATED
Trial details
- NCT number
- NCT05270265
- Sponsor
- University of Oxford
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-09
- Primary completion
- 2023-07-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.